Despite the continuous description of new conditions pre‐disposing for cerebral venous
thrombosis (CVT), no apparent cause is found in about 30% of cases …

Background: Idiopathic cerebral vein thrombosis (iCVT) represents approximately 30% of
the cases of cerebral vein thrombosis (CVT). New, inherited–factor V Leiden (FVL) and …

Background and Purpose—Elevated plasma levels of homocysteine are associated with an
increased risk of deep-vein thrombosis. Through a case–control study, we examined the …

High plasma levels of total homocysteine (tHcy) are a risk factor for deep vein thrombosis.
Because no information on the relationship between cerebral vein thrombosis and …

Mild hyperhomocysteinemia is an established risk factor for deep vein thrombosis. We report
three patients with cerebral vein thrombosis (CVT) in which the only risk factor we were able …

Cerebral venous thrombosis (CVT) is a rare manifestation of venous thromboembolism
(VTE) and stroke. The aim of our systematic review was to provide an updated summary of …

The authors studied 16 consecutive cases of cerebral venous thrombosis (CVT). Clinical
outcome was good or excellent in 14 patients. Comprehensive hypercoagulable screening …

There is limited data on the role of hyperhomocysteinemia as a risk factor for cerebral veno-
sinus thrombosis (CVT) in Indians. We examined the association between plasma …

Background and Purpose—The mechanisms of ischemic stroke in young adults are poorly
understood. During the last years, several studies suggested a role for genetic factors …

Background Elevated plasma homocysteine (Hcy) levels are implicated in the development
of atherosclerotic and venous thromboembolic disease. A meta-analysis of the risk for …